Search

Context. Overuse of N fertiliser in vegetable cropping systems is known to release of nitric and nitrous oxide to the atmosphere in China. Optimisation of N fertilisation regimes has the potential to mitigate NO and [N.sub.2]O emissions from these N-rich systems. Aims. We investigated the effects of different N fertilisation regimes on NO and [N.sub.2]O emissions, and vegetable yields, with particular efforts to estimate annual direct emission factors of NO and [N.sub.2]O under different N fertilisation regimes in greenhouse vegetable fields. Methods. Annual NO and [N.sub.2]O fluxes were taken simultaneously using the static chamber-based method from a greenhouse vegetable system in south-east China with four N fertiliser treatments: (I) no N fertiliser (control); (2) chemical N fertiliser application (CF); (3) organic N fertiliser application (OF); and (4) organic-chemical mixed N fertiliser application (MF). Key results. N fertilisers significantly increased NO and [N.sub.2]O emissions. Direct emission factors of N fertiliser for NO and [N.sub.2]O were the largest for MF, with an average of 0.99% and 0.67%, respectively. Vegetable yields were only significantly enhanced under OF treatment. Conclusions. Relative to the use of chemical N fertiliser, the application of organic-chemical mixed N fertiliser showed not to be effective for mitigating NO and [N.sub.2]O emissions. Instead, sole application of organic N fertiliser was a viable option to enhance vegetable yields but without increasing NO and [N.sub.2]O emissions in greenhouse vegetable systems. Implications. Substituting the use of chemical N fertiliser with organic N fertiliser input could benefitvegetable production but without stimulating NO and [N.sub.2]O emissions from vegetable cropping systems in sub-tropical China. Keywords: emissions factor, greenhouse vegetable field, nitric oxide, nitrous oxide, NO/[N.sub.2]O ratio, organic fertiliser, vegetable yields, WFPS., Introduction Nitric (NO) and nitrous oxide ([N.sub.2]O) are two trace gases that play critical roles in global nitrogen cycle. Both NO and [N.sub.2]O are involved in atmospheric photochemistry processes and [...]

Background: Levels of C-reactive protein (CRP) and alpha-fetoprotein (AFP) in immunotherapy (CRAFITY) scores are associated with the prognosis of patients with hepatocellular carcinoma (HCC). This study aimed to explore the efficacy of lenvatinib and pembrolizumab (Len-P) based on the CRAFITY score. Methods: In this study, 228 patients with HCC who received Len-P in Sun Yat-sen University Cancer Center were included. CRAFITY 0 score was defined as AFP level below 100 ng/ml, CRP level below 1 mg/dl, CRAFITY 1 score was defined as AFP level at least 100 ng/ml or CRP level at least 1 mg/dl. CRAFITY 2 scores were defined as AFP levels exceeding 100 ng/ml and CRP levels exceeding 100 ng/ml. The primary outcome was overall survival (OS). The second outcome was tumor response rate. Results: The survival time of CRAFITY 0 is significantly longer than that of CRAFITY 1 and CRAFITY 2 (p =.044). Univariate analysis showed that largest tumor size (HR = 2.149; 95% CI 1.129 - 4.091; p =.02), lymph node metastasis (HR = 2.012; 95% CI 1.132- 3.579; p =.017), and CRAFITY (HR = 0.372; 95% CI 0.168-0.824; p =.015) were important risk determinants of OS in all patients. The results of multivariate analysis show that CRAFITY score is an independent risk factors for OS (HR = 0.719; 95% CI 0.377-1.374; p =.048). The ORR of CRAFITY 0, 1 and 2 scores were 36.4%, 32% and 27.4%, respectively (p =.556). The ORR of intrahepatic lesions by CRAFITY 0, 1 and 2 were 37.9%, 35%, 30.6% (p =.688). Conclusion: CRAFITY score is a good predictor of prognosis in HCC patients receiving Len-P. [ABSTRACT FROM AUTHOR]

The curative effect of Huoxue Huayu Recipe combined with ibuprofen in the postoperative pain in patients with ankle fractures was analyzed. 68 patients with ankle fractures were divided into study group (n = 34, Huoxue Huayu Decoction combined with ibuprofen) and control group (n = 34, ibuprofen). The levels of inflammatory factors, ankle joint function, VAS score and bone metabolism indexes were compared. Complications, isokinetic muscle strength and clinical related index levels were compared after treatment. High AOFAS score and low VAS score were identified in the study group compared with the control group at 1 week, 1 month and 2 months after operation. Compared to the control group, the incidence of postoperative complications was declined in the study group. After treatment, IL-6 and TNF-α levels in both groups were significantly decreased, and the study group had lower IL-6 and TNF-α levels. After treatment, the torque acceleration energy, relative peak torque value and endurance in the study group were obviously improved. The disappearance time of swelling and pain, fracture healing time, and complete weight-bearing time in the study group were reduced compared to the control group. After treatment, BGP and BALP levels in study group were higher than control group. Huoxue Huayu Recipe combined with ibuprofen can reduce inflammatory factors levels in patients with ankle fracture, improve isokinetic muscle strength and ankle function, and accelerate the recovery of patients. [ABSTRACT FROM AUTHOR]

Background Little is known about the role of vitamin D receptor polymorphisms and their interaction with vitamin D status in hepatocellular carcinoma (HCC) prognosis. Methods We evaluated the association of TaqI , BsmI , Cdx-2, and ApaI polymorphisms, individually and in combination, with liver cancer-specific (LCSS) and overall survival (OS) among 967 patients with newly diagnosed HCC. Subsequently, we examined whether these polymorphisms modified the association between serum bioavailable 25-hydroxyvitamin D (25OHD) concentrations and survival. Cox proportional hazard models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Results During a median follow-up of 1017 days, 393 deaths occurred, with 360 attributed to HCC. Having TaqI G allele (HRper allele = 1.30, 95% CI = 1.08 to 1.57) or BsmI T allele (HRper allele = 1.41, 95% CI = 1.01 to 1.99) was associated with worse LCSS. Carrying increasing numbers of protective alleles was associated with superior LCSS (HR6-8 vs 0-3 = 0.52, 95% CI = 0.34 to 0.80). The inverse association of bioavailable 25OHD with LCSS was statistically significant only in patients with TaqI AA (HRQuartile 4 vs Quartile 1 = 0.63, 95% CI = 0.44 to 0.92), BsmI CC (HRQuartile 4 vs Quartile 1 = 0.62, 95% CI = 0.44 to 0.88), and 6 to 8 protective alleles (HRQuartile 4 vs Quartile 1 = 0.45, 95% CI = 0.23 to 0.87). Similar associations were observed for OS. Conclusions Patients carrying wild-type TaqI , BsmI , or more protective alleles had improved survival and might benefit from optimizing bioavailable 25OHD status. [ABSTRACT FROM AUTHOR]

Peritumoral hepatocytes are critical components of the liver cancer microenvironment, However, the role of peritumoral hepatocytes in the local tumor immune interface and the underlying molecular mechanisms have not been elucidated. YTHDF2, an RNA N6-methyladenosine (m6A) reader, is critical for liver tumor progression. The function and regulatory roles of YTHDF2 in peritumoral hepatocytes are unknown. This study demonstrated that oxaliplatin (OXA) upregulated m6A modification and YTHDF2 expression in hepatocytes. Studies using tumor-bearing liver-specific Ythdf2 knockout mice revealed that hepatocyte YTHDF2 suppresses liver tumor growth through CD8+ T cell recruitment and activation. Additionally, YTHDF2 mediated the response to immunotherapy. Mechanistically, OXA upregulated YTHDF2 expression by activating the cGAS-STING signaling pathway and consequently enhanced the therapeutic outcomes of immunotherapeutic interventions. Ythdf2 stabilized Cx3cl1 transcripts in an m6A-dependent manner, regulating the interplay between CD8+ T cells and the progression of liver malignancies. Thus, this study elucidated the novel role of hepatocyte YTHDF2, which promotes therapy-induced antitumor immune responses in the liver. The findings of this study provide valuable insights into the mechanism underlying the therapeutic benefits of targeting YTHDF2. [ABSTRACT FROM AUTHOR]